Efficacy of intravenous immunoglobulin following plasma exchange in the management of ABO haemolytic disease of the newborn

Documenti analoghi

• The contemporary management of haemolytic disease of the fetus and newborn
  di: Mark D. Kilby, et al.
  Pubblicazione: (2025)
• Anti‐D prophylaxis should protect all newborns from haemolytic disease, regardless of their country of residence
  di: Marcela Contreras, et al.
  Pubblicazione: (2024)
• Cost‐effectiveness of cEK ‐preventive matched transfusion strategies for female transfusion recipients to prevent haemolytic disease of the foetus and newborn in the Dutch healthcare setting
  di: Jessie S. Luken, et al.
  Pubblicazione: (2026)
• Antibodies against glutamic acid decarboxylase in intravenous immunoglobulin preparations can affect the diagnosis of type 1 diabetes mellitus
  di: Tatsuki Miyamoto, et al.
  Pubblicazione: (2024)
• Use and availability of anti‐ RhD immunoglobulin in Colombia following the 2024 national shortage
  di: Mariana Barake‐Ramos, et al.
  Pubblicazione: (2026)